Cannabis and the brain

L Iversen - Brain, 2003 - academic.oup.com
The active compound in herbal cannabis, Δ9‐tetrahydrocannabinol, exerts all of its known
central effects through the CB1 cannabinoid receptor. Research on cannabinoid …

Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in …

M Schneider, M Koch - Neuropsychopharmacology, 2003 - nature.com
There is evidence from studies in humans and animals that a vulnerable period for chronic
cannabinoid administration exists during certain phases of development. The present study …

Early maternal deprivation as an animal model for schizophrenia

BA Ellenbroek, MA Riva - Clinical Neuroscience Research, 2003 - Elsevier
Since the aetiology and the neuropathology of schizophrenia still largely eludes us, the
development of animal models for this severe psychiatric disease has remained a difficult …

Substance use disorder comorbidity among inpatient youths with psychiatric disorder

H Swadi, C Bobier - Australian & New Zealand Journal of …, 2003 - journals.sagepub.com
Objective: Substance abuse/dependence has been reported to show significant association
with psychopathology, and is likely to influence the course and outcome of psychiatric …

Animal models in the genomic era: possibilities and limitations with special emphasis on schizophrenia

BA Ellenbroek - Behavioural pharmacology, 2003 - journals.lww.com
Although the advances in molecular genetics have revolutionized many areas of the life
sciences, they have, so far, been of limited use in the development of animal models for …

The causes of schizophrenia: neurodevelopment and other risk factors

K Dean, E Bramon, RM Murray - Journal of Psychiatric Practice®, 2003 - journals.lww.com
Understanding the etiology of schizophrenia has been a considerable challenge. The
neurodevelopmental hypothesis has held sway in recent years, focusing our attention on …

The concept of population prevention: application to schizophrenia

R Mojtabai, D Malaspina, E Susser - Schizophrenia Bulletin, 2003 - academic.oup.com
There is currently a debate about the appropriate approach to prevention of schizophrenia.
While many argue that prevention efforts should focus on individuals at high risk of …

Does dopamine sensitization underlie the association between schizophrenia and drug abuse?

EM Tsapakis, O Guillin, RM Murray - Current Opinion in Psychiatry, 2003 - journals.lww.com
Drugs that release dopamine, such as amphetamines and cocaine, have long been known
to be associated with schizophrenia. As Professor Stefanis pointed out many years ago …

[PDF][PDF] Consumidores de cannabis: una intervención terapéutica basada en los programas de disminución de daños y riesgos

J Royo-Isach, M Magrané, A Velilla, R Martí - Atención primaria, 2003 - core.ac.uk
etc.), por lo que sus efectos pueden presentar variaciones, alteraciones y hasta
intoxicaciones en función del estado y las mezclas de los productos utilizados.–El …

Uso de maconha na adolescência e risco de esquizofrenia

K Soares-Weiser, M Weiser… - Brazilian Journal of …, 2003 - SciELO Brasil
Editorial bém longitudinal, foi realizado numa população de 4.045 adolescentes e
demonstrou um aumento de quase três vezes no risco de sintomas psicóticos em …